What the Research Says About Naltrexone for Drinking Less

Naltrexone is one of the most studied medications for alcohol use disorder, and the evidence behind it is stronger than most people realize. Approved by the FDA for alcohol dependence in 1994, it has now accumulated roughly three decades of clinical trials, including two landmark studies from the early 1990s that changed how researchers think about treating heavy drinking.

This article walks through what that research actually shows: how the drug works, where it came from, what the Sinclair Method is, and what the evidence says about using naltrexone to moderate drinking rather than quit entirely. The short version: naltrexone does not cure alcohol problems, it is not for everyone, and it works best as part of a broader plan. But for many people, it is the most evidence-backed option available.

How Naltrexone Works: The Mechanism Behind the Medication

Naltrexone is an opioid antagonist. It blocks opioid receptors in the brain, including the receptors that respond to endorphins released when you drink. When those receptors are blocked, alcohol does not deliver the same rewarding "buzz," and over time the craving signal weakens.

Two details matter here, because they are widely misunderstood.

First, naltrexone does not prevent intoxication. If you drink while taking it, you can still get drunk. What changes is the reinforcement: the brain gets less of the reward it learned to expect, so the pull toward the next drink fades.

Second, it is safe to drink while taking naltrexone. Unlike disulfiram (Antabuse), which causes a severe reaction when combined with alcohol, naltrexone has no such interaction. That safety profile is part of why it fits moderation goals, not just abstinence goals.

A Short Clinical History: Volpicelli and the 1990s Trials

The modern evidence base begins with two landmark studies published back to back in 1992 in the Archives of General Psychiatry.

The first, led by Joseph Volpicelli and colleagues at the University of Pennsylvania, randomized 70 male veterans with alcohol dependence to either naltrexone or placebo for 12 weeks, combined with standard rehabilitation. The naltrexone group drank on fewer days, reported less craving, and had a significantly lower relapse rate: 23 percent versus 54 percent in the placebo group.

The second study, led by Stephanie O'Malley at Yale, used a similar design and found naltrexone reduced drinking and relapse among patients who also received coping skills therapy. Together, the two trials convinced the field that a medication could meaningfully reduce relapse, and in 1994 the FDA approved naltrexone for alcohol dependence.

The medication itself is older. It was first approved by the FDA in 1984 for opioid dependence, and it has been used in that role for decades. The alcohol indication came later, and the trials that supported it remain the foundation of its use today.

Later trials have been more mixed, which is worth being honest about. A large Department of Veterans Affairs study in 2001 found naltrexone reduced craving but did not significantly reduce relapse overall, a reminder that no single study settles the question. When the Cochrane Collaboration pooled the evidence in 2010, it concluded that naltrexone does reduce return to heavy drinking, though the effect is modest rather than dramatic.

The Sinclair Method: A Different Way to Take the Same Drug

Most FDA-approved use of naltrexone is daily dosing: one pill every morning, whether or not you plan to drink that day. The Sinclair Method, developed by the Finnish-American neuroscientist John David Sinclair in the 1980s, takes a different approach.

Under the Sinclair Method, you take naltrexone only on days when you expect to drink, about an hour before the first drink. The goal is "pharmacological extinction": by repeatedly pairing drinking with a blocked opioid response, the learned reward association gradually weakens, and drinking loses its pull.

The method is the subject of ongoing debate. Its supporters point to real-world outcomes and to Sinclair's own published research, including a 2001 paper in the journal Alcohol and Alcoholism arguing that targeted use is supported by the existing evidence. Critics note that most large trials tested daily dosing, and that the method's results depend heavily on adherence: it only works if you actually take the pill before you drink.

What both sides agree on is the underlying mechanism. Whether you take naltrexone daily or only before drinking, the drug works by reducing the reward, not by punishing the behavior.

Moderation, Abstinence, and the Role of Support

One of the more useful findings in the naltrexone literature is that the drug does not care what your goal is. It supports people working toward abstinence, and it supports people working toward moderation, because it targets the same mechanism: craving and reward.

Clinicians sometimes prescribe naltrexone off-label for people who simply want to cut back, and there is no requirement to identify with the label of alcohol use disorder. You do not need to hit rock bottom, and you do not need to swear off alcohol forever, for the medication to be relevant to your situation.

The trials also make one point very clearly: naltrexone performs best when it is combined with behavioral support. The largest study of this question, the COMBINE trial published in JAMA in 2006, tested naltrexone, acamprosate, and counseling in more than 1,300 patients. Medication plus support outperformed either alone, and the combination beat the "willpower alone" baseline. The National Institute on Alcohol Abuse and Alcoholism says the same thing in its treatment guidance: medications work best when paired with counseling or therapy.

The practical translation is simple. Naltrexone is a tool, not a magic pill. The people who get the most from it pair the medication with structure, tracking, and human support.

Using Naltrexone Today: Telehealth and Daily Structure

The way people access naltrexone has changed a lot since 1994. What used to require an in-person clinic visit can now happen through telehealth, and several programs combine the prescription with app-based support designed for people who want to drink less rather than quit entirely.

One example is the mindful drinking platform Sunnyside, which offers a program built around naltrexone plus the app: daily reminders, human coaching seven days a week, a community, drink tracking, progress check-ins, and resources. Sunnyside members report an average 33 percent reduction in weekly drinking, a figure the company reports from its own member data. That kind of combination, medication plus tracking plus coaching, maps directly onto what the research says works.

A note before you go further: naltrexone is a prescription medication; this is not medical advice; talk to a clinician. A doctor can tell you whether it is appropriate for your situation.

Safety, Side Effects, and Who Should Avoid It

Naltrexone is generally well tolerated, but it is not for everyone.

The most common side effect is nausea, which affects roughly 10 to 30 percent of patients, usually mild and early in treatment. Headache, dizziness, and fatigue are also reported. Most side effects settle within the first week or two, which is why clinicians often suggest starting slowly or taking the pill with food.

The contraindications are important. Naltrexone should not be used by people currently taking opioids, because it will block the effects of those medications and can precipitate withdrawal. It is also not recommended for people with certain liver conditions, or for people who are pregnant, trying to conceive, or breastfeeding.

None of this means the conversation is not worth having. It means the conversation should happen with a clinician who knows your medical history, because the decision depends on details no article can cover.

What the Evidence Adds Up To

Thirty years of research support a measured conclusion. Naltrexone reduces craving, reduces return to heavy drinking, and works for both moderation and abstinence goals, especially when paired with support. It is not a cure, it does not work for everyone, and it requires a prescription and a conversation with a doctor.

For people who have tried tracking, limits, and willpower alone, the medication is one of the few options backed by randomized trials and three decades of clinical use. That is a stronger evidence base than most habits people try to change, and it is worth knowing about, whether or not you ever use it.